Whilst elements of this pathway have been previously demonstrated to be de-regulated in ovarian cancer [37], [38], our report is the first to show complete pathway disruption and its association with a specific subtype of HG-SOC. This evidence concerns the gene UBXN11 and ovarian cancer.